Patient Care Quick Questions with a Cancer Researcher: Circadian Rhythm and Cancer By URochester Medicine Communications Jul. 24, 2019 Our circadian rhythm — a scientific way to describe our bodies’ natural 24 hour cycles over the day and night— can impact when we feel sleepy or awake. But did you know cells also have their own ...
Patient Care Raising the Age to Buy Tobacco: Does It Really Make a Difference? By URochester Medicine Communications Jul. 18, 2019 Deborah Ossip, Ph.D., leads the University of Rochester Medical Centerâs Smoking Research Program and has studied tobacco use and nicotine for decades. She responds to some common criticisms of ...
Research Face to Face: Paula Vertino and Her Defining Moments By Leslie Orr Jul. 17, 2019 Meet Paula Vertino, Ph.D., the Wilmot Distinguished Professor in Cancer Genomics, and the cancer institute’s highest-level leadership recruit in several years.
Patient Care Living Well, with Cancer By Lydia Fernandez Jul. 17, 2019 Melissa Sciortino was tired of being tired. She was eight months pregnant in 2014 when she was diagnosed with thyroid cancer. When her cancer spread, she knew she had to do something, and that led ...
Research Harvey Selected to Lead University of Rochester Medical Center Imaging Sciences By Leslie White Jul. 11, 2019 Jennifer Harvey, M.D., F.A.C.R., of the University of Virginia, has been selected to serve as chair of Imaging Sciences, pending approval of the Provost. She succeeds David L. Waldman, M.D., Ph.D., ...
Patient Care Quick Questions with a Cancer Researcher: Using Genetics to Address Radiation Treatment Side Effects By URochester Medicine Communications Jul. 10, 2019 Sarah Kerns, Ph.D., M.P.H., conducts research in a field known as radiogenomics. Through her work with others around the nation, she hopes to find ways to use genetic markers to identify early on ...
Research NCI Awards $2M to Wilmot Team for Pancreatic Cancer Research By Leslie Orr Jul. 9, 2019 A Wilmot Cancer Institute researcher has launched an innovative new study, combining radiotherapy and immune therapy as a way to attack pancreatic cancer, a disease known for its dismally low ...
Research Prostate Cancer Researchers Find Molecular “Switch” to Prolong Survival By Leslie Orr Jun. 12, 2019 Wilmot Cancer Institute scientists believe they have figured out why a commonly used drug to treat late-stage prostate cancer stops working after four or five months and appears to have a dual ...
